These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 38901506)

  • 21. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications and advancements of polysaccharide-based nanostructures for enhanced drug delivery.
    Kareemi AF; Likhitkar S
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113883. PubMed ID: 38615389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment.
    Curcio M; Farfalla A; Saletta F; Valli E; Pantuso E; Nicoletta FP; Iemma F; Vittorio O; Cirillo G
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32365886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional DNA Origami Nanoplatforms for Drug Delivery.
    Lu X; Liu J; Wu X; Ding B
    Chem Asian J; 2019 Jul; 14(13):2193-2202. PubMed ID: 31125182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA nanostructures for targeted drug delivery and imaging.
    Teodori L; Omer M; Kjems J
    RNA Biol; 2024 Jan; 21(1):1-19. PubMed ID: 38555519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Nanosystems to Prostate Cancer.
    da Silva LC; Carmoa FA; Nasciutti LE; Zancan P; Sathler PC; Cabral LM
    Curr Pharm Des; 2016; 22(39):5962-5975. PubMed ID: 27426128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biological applications of DNA nanomaterials: current challenges and future directions.
    Ma W; Zhan Y; Zhang Y; Mao C; Xie X; Lin Y
    Signal Transduct Target Ther; 2021 Oct; 6(1):351. PubMed ID: 34620843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA Nanostructures as Smart Drug-Delivery Vehicles and Molecular Devices.
    Linko V; Ora A; Kostiainen MA
    Trends Biotechnol; 2015 Oct; 33(10):586-594. PubMed ID: 26409777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA Nanotechnology-Enabled Drug Delivery Systems.
    Hu Q; Li H; Wang L; Gu H; Fan C
    Chem Rev; 2019 May; 119(10):6459-6506. PubMed ID: 29465222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclodextrin-Based Nanosystems as Drug Carriers for Cancer Therapy.
    Sivakumar PM; Peimanfard S; Zarrabi A; Khosravi A; Islami M
    Anticancer Agents Med Chem; 2020; 20(11):1327-1339. PubMed ID: 31490765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA Nanostructure as Smart Carriers for Drug Delivery.
    Ouyang X; Chao J; Su S; Fan C
    Methods Mol Biol; 2017; 1500():121-132. PubMed ID: 27813005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy.
    Liu J; Dong J; Zhang T; Peng Q
    J Control Release; 2018 Sep; 286():64-73. PubMed ID: 30031155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 38. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices.
    Zhang Y; Tang N; Zhou H; Zhu Y
    Biomed Pharmacother; 2024 Jul; 176():116840. PubMed ID: 38820975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional polymeric DNA nanostructure-decorated cellulose nanocrystals for targeted and stimuli-responsive drug delivery.
    Lee Y; Nam K; Kim YM; Yang K; Kim Y; Oh JW; Roh YH
    Carbohydr Polym; 2024 Sep; 340():122270. PubMed ID: 38858000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.